Quiròs-Roldan E, Sottini A, Gulletta M, Stellini R, Puoti M, Primi D, Imberti L
Terzo Laboratorio Analisi, Spedali Civili, Brescia, Italy.
Blood. 1996 Sep 15;88(6):2133-43.
The lymphoproliferative syndrome with large granular lymphocytes (LGL) is an heterogeneous disorder of unknown etiology. The analysis of T-cell receptor (TCR) genes rearrangements has shown that, in most cases, the disease is associated with clonal proliferation of CD8+CD57+ LGL. However, the putative neoplastic nature of these expansions remains questionable because clonal proliferations of CD8+ cells have recently been found also in physiologic conditions. To obtain more precise information on the mechanisms responsible for LGL expansions, we decided to compare the molecular characteristics of TCRBV chains expressed by LGL with different phenotype and function, but derived from the same patients. To this end, we characterized, at the molecular level, the TCR repertoires of fractionated T-cell populations of two unusual patients with concurrent expansions of CD4+CD57+ and CD4-CD57+ LGL. Our results show that the dominant TCRBV chains expressed by the different CD4+ and CD4- LGL populations were strictly oligoclonal. However, the molecular characteristics of the dominant V-D-J rearrangements also imply that the selection of these clones was not due to a neoplastic event. Rather, our data suggest that these particular LGL proliferations can be ascribed to a chronic T-cell-mediated immune response that involves recognition by the engaged TCR of antigens that are not necessarily presented to immune system in the classical major histocompatibility complex-restricted pathway.
伴有大颗粒淋巴细胞(LGL)的淋巴增殖综合征是一种病因不明的异质性疾病。对T细胞受体(TCR)基因重排的分析表明,在大多数情况下,该疾病与CD8 + CD57 + LGL的克隆性增殖有关。然而,这些扩增的假定肿瘤性质仍然存在疑问,因为最近在生理条件下也发现了CD8 +细胞的克隆性增殖。为了获得有关LGL扩增机制的更精确信息,我们决定比较由不同表型和功能但来自同一患者的LGL表达的TCRBV链的分子特征。为此,我们在分子水平上对两名同时出现CD4 + CD57 +和CD4 - CD57 + LGL扩增的异常患者的分级T细胞群体的TCR库进行了表征。我们的结果表明,不同的CD4 +和CD4 - LGL群体表达的主要TCRBV链严格为寡克隆。然而,主要V - D - J重排的分子特征也表明这些克隆的选择并非由于肿瘤事件。相反,我们的数据表明,这些特定的LGL增殖可归因于慢性T细胞介导的免疫反应,该反应涉及参与的TCR识别不一定通过经典的主要组织相容性复合体限制途径呈递给免疫系统的抗原。